Please login to the form below

Not currently logged in
Email:
Password:

Patients Who

This page shows the latest Patients Who news and features for those working in and with pharma, biotech and healthcare.

GSK gets maintenance indication for Trelegy

GSK gets maintenance indication for Trelegy

GSK gets maintenance indication for Trelegy. Will now treat airflow obstruction in COPD patients. ... The new US label means Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) can be used in a broader population of chronic obstructive

Latest news

  • Otsuka finally gets FDA OK for kidney disease drug Otsuka finally gets FDA OK for kidney disease drug

    Otsuka – which will sell tolvaptan under the Jynarque brand name in the US – says the drug is the first treatment to slow the decline in kidney function in these patients, who ... For the past 35 years, our goal has been to support PKD patients from

  • Merck preps regulatory filings for much-needed antibiotic combo Merck preps regulatory filings for much-needed antibiotic combo

    If licensed, the new triple antibiotic would provide a new treatment option for patients who have acquired a serious infection caused by multi-drug resistant (MDR) and carbapenem-resistant Gram-negative ... Infections caused by Gram-negative bacteria

  • Daiichi Sankyo collaborates on e-patient AF resource Daiichi Sankyo collaborates on e-patient AF resource

    Daiichi Sankyo is collaborating with European e-patients platform People Who on a new atrial fibrillation (AF) resource. ... The target audience for the resource ranges from patients who have been diagnosed with AF, those caring for someone with the

  • Creating a big impact with data in sales Creating a big impact with data in sales

    Patients are taking greater control over their own treatments and are sharing their experiences and views on medicines via social networks, increasingly defining what they are happy to be prescribed by ... By performing analysis on unstructured data from

  • Bayer’s Nexavar recommended for thyroid cancer in EU Bayer’s Nexavar recommended for thyroid cancer in EU

    As such, Nexavar's recommendation could be an important step in the field, and covers its use in patients who no longer respond to treatment with radioactive iodine. ... This adds to its existing indications in the prevention of stroke in patients with

More from news
Approximately 1 fully matching, plus 1,004 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    A study recently reported in The Lancet Infectious Diseases found that antibiotics are now failing to work in a fifth of patients who suffer an infection after hospital surgery. ... This means ensuring that there are clear financial rewards available to

  • Beyond caring: learning from the unsung advocates in cancer care

    This would offer crucial face-to-face advice and support to patients who don’t have an advocate of their own, building a trusting relationship through compassion. ... Through a service such as this, the inequalities among patients and their carers

  • The challenges of making genomics a reality for patients The challenges of making genomics a reality for patients

    But our approach and success also hinges on patients being able to access our medicines. ... To. make this a reality for all patients who could benefit from precision medicines, we need to work together.

  • A new era of smart pharma A new era of smart pharma

    GDPR’s stipulation that patients who grant companies the use of their data can withdraw consent at any time and have it deleted (‘right to erasure’) contradicts regulations governing the integrity ... A new world of healthcare. Digital health is

  • The Patient Safety Challenge The Patient Safety Challenge

    It is estimated that around one in ten patients are harmed while receiving care. ... The most frequent types of errors are linked to patients’medication at the point of prescribing, dispensing or administration.

More from intelligence
Approximately 0 fully matching, plus 84 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics